Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis

Sarah L May1, Qing Zhou2, Mitzi Lewellen1

  • 1Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, Minnesota, United States of America.

Plos One
|June 20, 2014
PubMed

Insights

Nuclear factor of activated T cells 2 (Nfatc2) and T-cell activation inhibitor 1 (Tob1) are key regulators of T cell activation. Nfatc2 deficiency, but not Tob1 deficiency, leads to T cell accumulation and B-cell malignancies in mice.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Biology

Background:

  • Nfatc2 and Tob1 are intrinsic negative regulators of T cell activation.
  • The independent or overlapping roles of Nfatc2 and Tob1 in regulating T cell responses remain unclear.

Purpose of the Study:

  • To investigate the distinct and overlapping roles of Nfatc2 and Tob1 in T cell regulation and lymphocyte homeostasis.

Main Methods:

  • Comparison of T cell activation, proliferation, and regulatory function in Nfatc2 knockout (KO) and Tob1 KO mice.
  • In vivo analysis of T cell populations, memory cell compartment, and organ infiltrates.
  • In vitro assessment of T cell proliferation and regulatory T cell (Treg) suppressive activity.
  • Evaluation of B-cell malignancies in KO mice.

Main Results:

  • Nfatc2 KO mice, unlike Tob1 KO mice, exhibited age-associated accumulation of persistently activated T cells, expanded memory cell compartment, and organ lymphocytic infiltrates.
  • Both Nfatc2 KO and Tob1 KO conventional T cells (Tconvs) showed increased proliferation in vitro.
  • Tregs from Nfatc2 KO mice maintained normal suppressive function, while Tob1 KO Tregs displayed enhanced suppressive activity.
  • Nfatc2 KO mice developed increased B-cell malignancies, independent of Tob1 absence.

Conclusions:

  • Nfatc2 and Tob1 function as non-redundant regulators of lymphocyte homeostasis.
  • Nfatc2 plays a critical role in preventing age-associated T cell activation and B-cell malignancies.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

1.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K